Patents by Inventor Steven Hannick

Steven Hannick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES
    Publication number: 20160145197
    Abstract: The present invention provides a process for preparing a bicyclic amine derivative of the formula (Ia) or (Ib), comprising the rhodium-catalyzed asymmetric hydrogenation of an enamine of the formula (II), in the presence of a chiral ligand, wherein the chiral ligand is a chiral phosphine ligand.
    Type: Application
    Filed: November 24, 2015
    Publication date: May 26, 2016
    Inventors: Yi-Yin Ku, Steven Hannick, Ashok K. Gupta
  • Process for preparing bicyclic amine derivatives
    Patent number: 9227901
    Abstract: The present invention provides a process for preparing a bicyclic amine derivative of the formula (Ia) or (Ib), comprising the rhodium-catalyzed asymmetric hydrogenation of an enamine of the formula (II), in the presence of a chiral ligand, wherein the chiral ligand is a chiral phosphine ligand.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: January 5, 2016
    Assignee: AbbVie Inc.
    Inventors: Yi-Yin Ku, Steven Hannick, Ashok K. Gupta
  • PROCESS FOR PREPARING BICYCLIC AMINE DERIVATIVES
    Publication number: 20140012015
    Abstract: The present invention provides a process for preparing a bicyclic amine derivative of the formula (Ia) or (Ib), comprising the rhodium-catalyzed asymmetric hydrogenation of an enamine of the formula (II), in the presence of a chiral ligand, wherein the chiral ligand is a chiral phosphine ligand.
    Type: Application
    Filed: July 2, 2013
    Publication date: January 9, 2014
    Inventors: Yi-Yin Ku, Steven Hannick, Ashok K. Gupta
  • RETROVIRAL PROTEASE INHIBITING COMPOUNDS
    Publication number: 20080139811
    Abstract: A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
    Type: Application
    Filed: February 27, 2007
    Publication date: June 12, 2008
    Inventors: Hing Sham, Daniel Norbeck, Xiaoqi Chen, David Betebenner, Dale Kempf, Thomas Herrin, Gondi Kumar, Stephen Condon, Arthur Cooper, Daniel Dickman, Steven Hannick, Lawrence Kolaczkowski, Patricia Oliver, Daniel Plata, Peter Stengel, Eric Stoner, Jieh-Heh Tien, Jih-Hua Liu, Ketan Patel
  • (1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6-DIAZABICYCLO[3.2.0]HEPTANE
    Publication number: 20080070891
    Abstract: The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.
    Type: Application
    Filed: August 14, 2007
    Publication date: March 20, 2008
    Inventors: Michael Buckley, Jianguo Ji, Geoff Zhang, Rodger Henry, Weili Wang, Gregory Wayne, Wenke Li, Timothy Towne, Steven Wittenberger, Steven Hannick, Brian Kotecki, Bryan Macri, Timothy Robbins
  • (1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6-DIAZABICYCLO[3.2.0]HEPTANE
    Publication number: 20060035936
    Abstract: The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic acetylcholine receptor.
    Type: Application
    Filed: July 7, 2005
    Publication date: February 16, 2006
    Inventors: Michael Buckley, Jianguo Ji, Geoff Zhang, Rodger Henry, Weili Wang, Gregory Wayne, Wenke Li, Timothy Towne, Steven Wittenberger, Steven Hannick, Brian Kotecki, Bryan Macri, Timothy Robbins
  • Synthesis of acyclic nucleoside derivatives
    Publication number: 20050250795
    Abstract: Methods and novel intermediates for the preparation of acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 18, 2005
    Publication date: November 10, 2005
    Applicant: Medivir AB
    Inventors: M. Leanna, Steven Hannick, Michael Rasmussen, Jien-Heh Tien, Lakshmi Bhagavatula, Pulla Singam, Bradley Gates, Lawrence Kolaczkowski, Ramesh Patel, Greg Wayne, Greg Lannoye, Weijiang Zhang, Zhenping Tian, Kirill Lukin, Bikshandarkoil Narayanan, David Riley, Howard Morton, Sou-Jen Chang, Cynthia Curty, Daniel Plata, John Bellettini, Bhadra Shelat, Tiffany Spitz, Cheng-Xi Yang